CCL2 and metabolic dysfunction-associated steatotic liver disease: In conclusion, supplementation with 0.5–1% of LCBP in diet decreased significantly the levels of inflammatory cytokines, including IL-2, IL-6, MCP-1, and TNF-α, in serum, as well as endotoxin levels in both serum and liver in a mice model of NAFLD.